𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sunitinib: From Rational Design to Clinical Efficacy

✍ Scribed by Chow, L. Q.M.; Eckhardt, S. G.

Book ID
111893281
Publisher
American Society of Clinical Oncology
Year
2007
Tongue
English
Weight
248 KB
Volume
25
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sunitinib: From Rational Design to Clini
Sunitinib: From Rational Design to Clinical Efficacy
✍ Chow, L. Q.M.; Eckhardt, S. G. πŸ“‚ Article πŸ“… 2007 πŸ› American Society of Clinical Oncology 🌐 English βš– 248 KB

Sunitinib (SU011248) is an oral small molecular tyrosine kinase inhibitor that exhibits potent antiangiogenic and antitumor activity. Tyrosine kinase inhibitors such as SU6668 and SU5416 (semaxanib) demonstrated poor pharmacologic properties and limited efficacy; therefore, sunitinib was rationally

Tyrosine kinase inhibitors: From rationa
Tyrosine kinase inhibitors: From rational design to clinical trials
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

## Abstract Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms. The inhibition of growth related kinases, especially tyrosine kinases, might provide new therapies for diseases such as cancer. The progre

ChemInform Abstract: Tyrosine Kinase Inh
ChemInform Abstract: Tyrosine Kinase Inhibitors: From Rational Design to Clinical Trials.
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v